DENNIS W SHULTS

Allopathic & Osteopathic Physicians|Family Medicine BREA, CA NPI 1043370026

General Payments — all program years on this page

$181,158.78

  • Category: General Payments
  • Program years: PY2021–2024
  • Record count: 85
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $103,833.78 across 49 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Consulting Fee $103,275.0043
Travel and Lodging $558.786

By paying entity

Latest program year (PY2024) · sorted by reported total.

Paying entityAmountRecords
Takeda Pharmaceuticals U.S.A., Inc. $103,833.7849

By program year

Program yearAmountRecords
2021 $17,875.009
2022 $31,200.0012
2023 $28,250.0015
2024 $103,833.7849

Records — PY2024 (49)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1137675607 Takeda Pharmaceuticals U.S.A., Inc. $2,700.00 01/17/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1137675609 Takeda Pharmaceuticals U.S.A., Inc. $2,700.00 01/17/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1137675611 Takeda Pharmaceuticals U.S.A., Inc. $675.00 01/24/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1137675613 Takeda Pharmaceuticals U.S.A., Inc. $675.00 02/09/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1137675615 Takeda Pharmaceuticals U.S.A., Inc. $2,700.00 02/14/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1137675617 Takeda Pharmaceuticals U.S.A., Inc. $2,700.00 02/14/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1137675619 Takeda Pharmaceuticals U.S.A., Inc. $675.00 02/16/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1137675621 Takeda Pharmaceuticals U.S.A., Inc. $2,700.00 03/11/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1137675623 Takeda Pharmaceuticals U.S.A., Inc. $2,700.00 03/11/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1137675625 Takeda Pharmaceuticals U.S.A., Inc. $675.00 04/03/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1137675627 Takeda Pharmaceuticals U.S.A., Inc. $2,700.00 04/17/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1137675629 Takeda Pharmaceuticals U.S.A., Inc. $2,700.00 04/17/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1137675631 Takeda Pharmaceuticals U.S.A., Inc. $675.00 05/08/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1137675633 Takeda Pharmaceuticals U.S.A., Inc. $2,700.00 05/10/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1137675635 Takeda Pharmaceuticals U.S.A., Inc. $2,700.00 05/10/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1137675637 Takeda Pharmaceuticals U.S.A., Inc. $675.00 05/17/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1137675639 Takeda Pharmaceuticals U.S.A., Inc. $2,700.00 06/10/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1137675641 Takeda Pharmaceuticals U.S.A., Inc. $2,700.00 06/10/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1137675643 Takeda Pharmaceuticals U.S.A., Inc. $2,700.00 07/12/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1137675645 Takeda Pharmaceuticals U.S.A., Inc. $2,700.00 07/12/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1137675647 Takeda Pharmaceuticals U.S.A., Inc. $2,700.00 07/12/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1137675649 Takeda Pharmaceuticals U.S.A., Inc. $2,700.00 08/09/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1137675651 Takeda Pharmaceuticals U.S.A., Inc. $2,700.00 08/09/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1137675653 Takeda Pharmaceuticals U.S.A., Inc. $2,700.00 08/21/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1137675655 Takeda Pharmaceuticals U.S.A., Inc. $2,700.00 09/11/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1137675657 Takeda Pharmaceuticals U.S.A., Inc. $2,700.00 09/11/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1137675659 Takeda Pharmaceuticals U.S.A., Inc. $2,700.00 10/02/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1137675661 Takeda Pharmaceuticals U.S.A., Inc. $99.16 10/02/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1137675663 Takeda Pharmaceuticals U.S.A., Inc. $2,700.00 10/02/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1137675665 Takeda Pharmaceuticals U.S.A., Inc. $75.71 10/02/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1137675667 Takeda Pharmaceuticals U.S.A., Inc. $2,700.00 10/09/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1137675669 Takeda Pharmaceuticals U.S.A., Inc. $2,700.00 10/09/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1137675671 Takeda Pharmaceuticals U.S.A., Inc. $2,700.00 10/14/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1137675673 Takeda Pharmaceuticals U.S.A., Inc. $2,700.00 10/14/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1137675675 Takeda Pharmaceuticals U.S.A., Inc. $2,700.00 11/04/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1137675677 Takeda Pharmaceuticals U.S.A., Inc. $113.90 11/04/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1137675679 Takeda Pharmaceuticals U.S.A., Inc. $2,700.00 11/13/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1137675681 Takeda Pharmaceuticals U.S.A., Inc. $2,700.00 11/13/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1137675683 Takeda Pharmaceuticals U.S.A., Inc. $2,700.00 11/15/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1137675685 Takeda Pharmaceuticals U.S.A., Inc. $2,700.00 11/15/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1137675687 Takeda Pharmaceuticals U.S.A., Inc. $100.50 11/15/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1137675689 Takeda Pharmaceuticals U.S.A., Inc. $2,700.00 11/15/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1137675691 Takeda Pharmaceuticals U.S.A., Inc. $84.42 11/15/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1137675693 Takeda Pharmaceuticals U.S.A., Inc. $2,700.00 11/15/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1137675695 Takeda Pharmaceuticals U.S.A., Inc. $85.09 11/15/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1137675697 Takeda Pharmaceuticals U.S.A., Inc. $2,700.00 12/09/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1137675699 Takeda Pharmaceuticals U.S.A., Inc. $2,700.00 12/09/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1137675701 Takeda Pharmaceuticals U.S.A., Inc. $2,025.00 12/09/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1137675703 Takeda Pharmaceuticals U.S.A., Inc. $2,700.00 12/09/2024 Consulting Fee Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.